Developer docs
API playgroundTry for free, no card

Search company profiles

CrossRoads Extremity Systems

Full company profile

uuid0002qvg

Namestring
CrossRoads Extremity Systems
Legal namestring
CrossRoads Extremity Systems
Websiteurl
crextremity.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

CrossRoads Extremity Systems is a Memphis, Tennessee-based medical device manufacturer founded in 2014 that designs and commercializes proprietary implant systems for foot and ankle surgery. Its flagship product is the miniBunion® 3D system, a minimally invasive bunion correction procedure that realigns the toe in three dimensions through a 1.5-inch incision and stabilizes it with a proprietary micro-implant, enabling most patients to walk immediately after surgery using a postoperative shoe. The portfolio is extended by the dynaBunion® 4D Bunion System for severe bunion cases and the MotoBAND™ CP and MotoCLIP™ implant systems, which are indicated for stabilization and fixation of fractures, revision procedures, joint fusion, and reconstruction of small bones in the hand, feet, wrist, ankles, fingers, and toes. The company is registered with four trademarks spanning these product lines.

The company sells exclusively to healthcare providers, not patients, using an enterprise field sales motion that targets orthopedic surgeons and podiatrists specializing in foot and ankle procedures. Its products are commercially available across 22 U.S. states, and the company supports surgeon adoption and patient demand generation through a dedicated patient education site (minibunion.com), a Surgeon Finder tool, patient testimonials, and surgeon resource content. The business model is hardware-based per-procedure implant sales; pricing is not publicly disclosed but the procedures are classified as standard bunion correction and are covered by most insurance policies.

CrossRoads has raised approximately $19.7M in disclosed funding across 2014-2021, with MB Venture Partners as an early backer and Runway Growth Capital leading a $15M round in July 2021. Leadership includes co-founder Chad Hollis (VP of R&D), CEO and President Vernon Hartdegen, CFO Tim Slayton, and VP of Marketing Alex Winber. The company operates as a private, for-profit business with 51-100 employees.

Short descriptiontext

CrossRoads Extremity Systems is a Memphis-based medical device manufacturer that designs and sells proprietary micro-implant systems for minimally invasive foot and ankle surgery, including the miniBunion 3D and dynaBunion 4D bunion correction systems, to trained surgeons across 22 U.S. states.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMemphis, United States
HQ citystring
Memphis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
foot and ankle implants, minimally invasive surgery, bunion correction systems, orthopedic medical devices, small bone fixation
Industry1 code
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Orthopedic Foot and Ankle Implants
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Surgical Implant Sales
TypeHardware Sales
Description

Revenue generated from the sale of proprietary medical implants (miniBunion 3D micro-implants, dynaBunion 4D systems, MotoBAND CP, and MotoCLIP implant systems) to hospitals, surgical centers, and foot surgeons performing bunion correction and related foot/ankle procedures.

minibunion.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1miniBunion 3D
Description

Minimally invasive bunion surgery procedure with a 3D alignment approach using a micro-implant through a small 1.5-inch incision.

minibunion.com
+3 more records
Core offering1 text field

CrossRoads Extremity Systems designs, manufactures, and sells proprietary foot and ankle implant systems used by orthopedic surgeons and podiatrists to perform minimally invasive bunion correction and small bone fixation procedures. Its core products include the miniBunion 3D and dynaBunion 4D bunion correction systems along with the MotoBAND CP and MotoCLIP implant systems for stabilization and fixation of fractures, fusions, and reconstructions of small bones in the hand, feet, wrist, ankles, fingers and toes. The company sells its implants through a network of trained surgeons across 22 U.S. states rather than directly to patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Most patients can begin walking immediately after surgery using a specialized postoperative shoe, compared to traditional surgery requiring 8-10 weeks in a cast or bulky postoperative boot with crutches.
Product overview1 text field

CrossRoads Extremity Systems offers a portfolio of minimally invasive bunion correction procedures and surgical implant systems. The core offerings include the miniBunion® 3D procedure for mild to moderate bunions and the dynaBunion® 4D Bunion System for severe cases. Supporting these procedures are the MotoBAND™ CP and MotoCLIP™ implant systems for bone stabilization and fixation across various foot, ankle, hand, and wrist procedures.

Product and service4 records
1miniBunion 3D
CategoryBunion correction implant system
2dynaBunion 4D Bunion System
3MotoBAND CP Implant System
4MotoCLIP Implant System
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Zimmer Biomet offers foot & ankle surgical products within its broader orthopedic portfolio and serves many of the same hospital and ASC customers as CrossRoads.

TypeBroad incumbent
Description

Smith+Nephew operates a global Extremities portfolio (foot & ankle plating, soft tissue, and related fixation) that overlaps with CrossRoads' MotoBAND/MotoCLIP and bunion products in the same surgical settings.

TypeBroad incumbent
Description

Stryker's Foot & Ankle business (built around the Wright Medical acquisition) offers plates, screws, and other fixation implants for forefoot and midfoot procedures; competes with CrossRoads' MotoBAND/MotoCLIP and bunion fixation in the same surgeon accounts, but as part of a much larger orthopedic portfolio.

TypeEmerging player
Description

Additive Orthopaedics develops 3D-printed foot and ankle implants and procedural solutions targeting the same forefoot and midfoot indications that CrossRoads addresses with its MIS bunion and fixation systems.

TypeBroad incumbent
Description

Integra's Extremity Orthopedics segment includes foot & ankle implants and fixation products sold through orthopedic and podiatric surgeon channels; competes with CrossRoads' bunion and small-bone fixation portfolios.

TypeDirect peer
Description

Treace's Lapiplasty system is the most established 3D bunion correction platform in the U.S., addressing the same patient population and surgical indication as CrossRoads' miniBunion 3D and dynaBunion 4D; both companies compete for foot & ankle surgeon mindshare in minimally invasive bunion correction.

TypeBroad incumbent
Description

Arthrex is a leading extremity-focused orthopedic device company with deep foot & ankle coverage and a large MIS-focused surgeon training network; competes broadly with CrossRoads in small-bone fixation and bunion correction instrumentation.

8Paragon 28
TypeDirect peer
Description

Pure-play foot and ankle medical device company offering a broad portfolio of plating, fixation, and soft-tissue implants for foot and ankle surgeons; directly comparable as a specialist extremities competitor also selling through foot & ankle surgeon channels.

TypeBroad incumbent
Description

Conmed has a dedicated foot & ankle business offering plating and fixation devices aimed at foot and ankle surgeons, overlapping with CrossRoads' MotoBAND/MotoCLIP implants in the same procedure types.

TypeEmerging player
Description

Voom Medical Devices markets the Voom BunionFix minimally invasive bunion correction platform, a direct MIS-bunion competitor to CrossRoads' miniBunion 3D and dynaBunion 4D for foot and ankle surgeons.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CrossRoads Extremity Systems

Orthopedic Foot and Ankle Implantscrextremity.com

CrossRoads Extremity Systems is a Memphis-based medical device manufacturer that designs and sells proprietary micro-implant systems for minimally invasive foot and ankle surgery, including the miniBunion 3D and dynaBunion 4D bunion correction systems, to trained surgeons across 22 U.S. states.

What CrossRoads Extremity Systems does

CrossRoads Extremity Systems is a Memphis, Tennessee-based medical device manufacturer founded in 2014 that designs and commercializes proprietary implant systems for foot and ankle surgery. Its flagship product is the miniBunion® 3D system, a minimally invasive bunion correction procedure that realigns the toe in three dimensions through a 1.5-inch incision and stabilizes it with a proprietary micro-implant, enabling most patients to walk immediately after surgery using a postoperative shoe. The portfolio is extended by the dynaBunion® 4D Bunion System for severe bunion cases and the MotoBAND™ CP and MotoCLIP™ implant systems, which are indicated for stabilization and fixation of fractures, revision procedures, joint fusion, and reconstruction of small bones in the hand, feet, wrist, ankles, fingers, and toes. The company is registered with four trademarks spanning these product lines.

The company sells exclusively to healthcare providers, not patients, using an enterprise field sales motion that targets orthopedic surgeons and podiatrists specializing in foot and ankle procedures. Its products are commercially available across 22 U.S. states, and the company supports surgeon adoption and patient demand generation through a dedicated patient education site (minibunion.com), a Surgeon Finder tool, patient testimonials, and surgeon resource content. The business model is hardware-based per-procedure implant sales; pricing is not publicly disclosed but the procedures are classified as standard bunion correction and are covered by most insurance policies.

CrossRoads has raised approximately $19.7M in disclosed funding across 2014-2021, with MB Venture Partners as an early backer and Runway Growth Capital leading a $15M round in July 2021. Leadership includes co-founder Chad Hollis (VP of R&D), CEO and President Vernon Hartdegen, CFO Tim Slayton, and VP of Marketing Alex Winber. The company operates as a private, for-profit business with 51-100 employees.

CrossRoads Extremity Systems firmographics

Firmographics
Name
CrossRoads Extremity Systems
Legal name
CrossRoads Extremity Systems
Website
https://crextremity.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
CrossRoads Extremity Systems is a Memphis-based medical device manufacturer that designs and sells proprietary micro-implant systems for minimally invasive foot and ankle surgery, including the miniBunion 3D and dynaBunion 4D bunion correction systems, to trained surgeons across 22 U.S. states.
Ownership category
akta.pro rank

CrossRoads Extremity Systems industry classification

Industry
Product category
Orthopedic Foot and Ankle Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAB
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Foot and ankle implants
  • Minimally invasive surgery
  • Bunion correction systems
  • Orthopedic medical devices
  • Small bone fixation

Where CrossRoads Extremity Systems is headquartered

Location

Headquarters

HQ city
Memphis
HQ country
United States
HQ region
North America

Markets served

CrossRoads Extremity Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Surgical Implant Sales: Revenue generated from the sale of proprietary medical implants (miniBunion 3D micro-implants, dynaBunion 4D systems, MotoBAND CP, and MotoCLIP implant systems) to hospitals, surgical centers, and foot surgeons performing bunion correction and related foot/ankle procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

CrossRoads Extremity Systems product offering

Product offering

Core offering

CrossRoads Extremity Systems designs, manufactures, and sells proprietary foot and ankle implant systems used by orthopedic surgeons and podiatrists to perform minimally invasive bunion correction and small bone fixation procedures. Its core products include the miniBunion 3D and dynaBunion 4D bunion correction systems along with the MotoBAND CP and MotoCLIP implant systems for stabilization and fixation of fractures, fusions, and reconstructions of small bones in the hand, feet, wrist, ankles, fingers and toes. The company sells its implants through a network of trained surgeons across 22 U.S. states rather than directly to patients.

Product overview

CrossRoads Extremity Systems offers a portfolio of minimally invasive bunion correction procedures and surgical implant systems. The core offerings include the miniBunion® 3D procedure for mild to moderate bunions and the dynaBunion® 4D Bunion System for severe cases. Supporting these procedures are the MotoBAND™ CP and MotoCLIP™ implant systems for bone stabilization and fixation across various foot, ankle, hand, and wrist procedures.

Differentiator

Problem solved

Functional benefit

Brands

  • miniBunion 3D: Minimally invasive bunion surgery procedure with a 3D alignment approach using a micro-implant through a small 1.5-inch incision.
  • dynaBunion 4D Bunion System
  • MotoBAND CP Implant System
  • MotoCLIP Implant System

Products and services

  • miniBunion 3D
  • dynaBunion 4D Bunion System
  • MotoBAND CP Implant System
  • MotoCLIP Implant System

Quantifiable outcome

  • Most patients can begin walking immediately after surgery using a specialized postoperative shoe, compared to traditional surgery requiring 8-10 weeks in a cast or bulky postoperative boot with crutches.

Companies that use CrossRoads Extremity Systems

Customer profile

Segments2 records

Ideal customer profiles1 record

CrossRoads Extremity Systems technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

CrossRoads Extremity Systems partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

CrossRoads Extremity Systems competitors and assessment

Company assessment

Broad incumbents

  • Zimmer Biomet: Zimmer Biomet offers foot & ankle surgical products within its broader orthopedic portfolio and serves many of the same hospital and ASC customers as CrossRoads.
  • Smith+Nephew: Smith+Nephew operates a global Extremities portfolio (foot & ankle plating, soft tissue, and related fixation) that overlaps with CrossRoads' MotoBAND/MotoCLIP and bunion products in the same surgical settings.
  • Stryker: Stryker's Foot & Ankle business (built around the Wright Medical acquisition) offers plates, screws, and other fixation implants for forefoot and midfoot procedures; competes with CrossRoads' MotoBAND/MotoCLIP and bunion fixation in the same surgeon accounts, but as part of a much larger orthopedic portfolio.
  • Integra LifeSciences: Integra's Extremity Orthopedics segment includes foot & ankle implants and fixation products sold through orthopedic and podiatric surgeon channels; competes with CrossRoads' bunion and small-bone fixation portfolios.
  • Arthrex: Arthrex is a leading extremity-focused orthopedic device company with deep foot & ankle coverage and a large MIS-focused surgeon training network; competes broadly with CrossRoads in small-bone fixation and bunion correction instrumentation.
  • Conmed: Conmed has a dedicated foot & ankle business offering plating and fixation devices aimed at foot and ankle surgeons, overlapping with CrossRoads' MotoBAND/MotoCLIP implants in the same procedure types.

Emerging players

  • Additive Orthopaedics: Additive Orthopaedics develops 3D-printed foot and ankle implants and procedural solutions targeting the same forefoot and midfoot indications that CrossRoads addresses with its MIS bunion and fixation systems.
  • Voom Medical Devices: Voom Medical Devices markets the Voom BunionFix minimally invasive bunion correction platform, a direct MIS-bunion competitor to CrossRoads' miniBunion 3D and dynaBunion 4D for foot and ankle surgeons.

Direct peers

  • Treace Medical Concepts: Treace's Lapiplasty system is the most established 3D bunion correction platform in the U.S., addressing the same patient population and surgical indication as CrossRoads' miniBunion 3D and dynaBunion 4D; both companies compete for foot & ankle surgeon mindshare in minimally invasive bunion correction.
  • Paragon 28: Pure-play foot and ankle medical device company offering a broad portfolio of plating, fixation, and soft-tissue implants for foot and ankle surgeons; directly comparable as a specialist extremities competitor also selling through foot & ankle surgeon channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

CrossRoads Extremity Systems social profiles

Digital presence

CrossRoads Extremity Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CrossRoads Extremity Systems leadership team

Management profile

Number of profiles

Profiles4 records

CrossRoads Extremity Systems funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CrossRoads Extremity Systems M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CrossRoads Extremity Systems

What does CrossRoads Extremity Systems do?

CrossRoads Extremity Systems designs, manufactures, and sells proprietary foot and ankle implant systems used by orthopedic surgeons and podiatrists to perform minimally invasive bunion correction and small bone fixation procedures. Its core products include the miniBunion 3D and dynaBunion 4D bunion correction systems along with the MotoBAND CP and MotoCLIP implant systems for stabilization and fixation of fractures, fusions, and reconstructions of small bones in the hand, feet, wrist, ankles, fingers and toes. The company sells its implants through a network of trained surgeons across 22 U.S. states rather than directly to patients.

Is CrossRoads Extremity Systems a public or private company?

CrossRoads Extremity Systems is a private company. It is classified as venture growth investor backed and is currently operating.

When was CrossRoads Extremity Systems founded?

CrossRoads Extremity Systems was founded in 2014. It employs 51 to 100 people.

Where is CrossRoads Extremity Systems based?

CrossRoads Extremity Systems is headquartered in Memphis, United States, in the North America region.

How does CrossRoads Extremity Systems make money?

One revenue line is on record: surgical Implant Sales.

Who are CrossRoads Extremity Systems's main competitors?

Broad incumbents on record are Zimmer Biomet, Smith+Nephew, Stryker, Integra LifeSciences, Arthrex and Conmed. Emerging players are Additive Orthopaedics and Voom Medical Devices. Direct peers are Treace Medical Concepts and Paragon 28.

Does CrossRoads Extremity Systems have an API?

No public API is recorded for CrossRoads Extremity Systems.

What industry is CrossRoads Extremity Systems in?

CrossRoads Extremity Systems's product category is Orthopedic Foot and Ankle Implants. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireThe Global Orthopedic Digit Implants Market to Observe Impressive Growth at a CAGR of ~7% by 2027 | DelveInsightDelveInsight's Orthopedic Digit Implants Market Insights report projects the market to grow at approximately 7% CAGR, reaching USD 134.53 million by 2027, driven by an aging global population and rising rheumatoid arthritis prevalence. North America is expected to dominate the market due to its strong healthcare infrastructure and growing demand for minimally invasive surgeries. Notable recent developments include Arthrex receiving FDA clearance for pediatric ACL TightRope implants, Johnson & Johnson's DePuy Synthes acquiring CrossRoads Extremity Systems, and partnerships between Oxford Performance Materials and Jajal Medical for customized 3D-printed orthopedic implants.MassDeviceDePuy Synthes acquires CrossRoads Extremity SystemsJohnson & Johnson's subsidiary DePuy Synthes has acquired CrossRoads Extremity Systems, a Tennessee-based developer of implants and instrumentation for lower extremity procedures. This acquisition adds more than 25 products to DePuy Synthes' portfolio, including specific bunion correction systems and instrument services, aimed at expanding its offerings in elective foot and ankle surgery. Financial terms of the transaction were not disclosed.American City Business JournalsMemphis-based CrossRoads Extremity Systems, an orthopedic medical device company focused on implants and instrumentation related to the foot and ankle space, was acquired on Feb. 10 by DePuy Synthes,DePuy Synthes acquired Memphis-based CrossRoads Extremity Systems on Feb. 9, with terms undisclosed. The foot and ankle implant company, founded in 2014, has products used in over 25,000 surgeries. The deal was not disclosed.HealthpointcapitalHealthpointCapital Announces the Successful Sale of CrossRoads Extremity Systems to DePuy Synthes, The Orthopaedics Company of Johnson & JohnsonHealthpointCapital Management LLC has completed the sale of CrossRoads Extremity Systems to DePuy Synthes, a subsidiary of Johnson & Johnson. This transaction marks the first exit for HealthpointCapital's Musculoskeletal Fund and involves the acquisition of an innovative designer of foot and ankle surgery implants. Founders Vernon Hartdegen and Chad Hollis from CrossRoads will join DePuy Synthes following the deal.JnjmedtechDePuy Synthes Acquires CrossRoads® Extremity SystemsDePuy Synthes, a subsidiary of Johnson & Johnson, has acquired CrossRoads Extremity Systems, a Tennessee-based company specializing in foot and ankle medical devices. The acquisition brings several innovative products, including minimally invasive bunion correction systems, into DePuy Synthes' portfolio to address the growing demand for elective extremity procedures. This move is intended to expand surgical options for patients and strengthen DePuy Synthes' position in the orthopaedic market.PR NewswireHealthpointCapital Announces the Successful Sale of CrossRoads Extremity Systems to DePuy Synthes, The Orthopaedics Company of Johnson & JohnsonHealthpointCapital Management LLC has completed the sale of CrossRoads Extremity Systems to DePuy Synthes, a subsidiary of Johnson & Johnson. This transaction represents the first exit for HealthpointCapital's Musculoskeletal Fund and follows the company's strategic growth through asset acquisitions under private equity ownership.GlobeNewswireCrossRoads Breaks Through the Bunion Correction Market With Invisible Incision and Four-Dimensional ProductsCrossRoads Extremity Systems announced completion of its 5,000th bunion procedure, offering minimally invasive miniBunion 3D and dynaBunion 4D systems for mild to severe bunions. The company claims its systems enable walking recovery and continuous compression for faster healing.PR NewswireRunway Growth Capital Announces a Senior Secured Term Loan of $15 Million to CrossRoads Extremity SystemsRunway Growth Capital LLC has closed a $15 million senior secured term loan to CrossRoads Extremity Systems to support its growth in the foot and ankle orthopedic market. This transaction is part of Runway's recent activity in the life sciences sector, which includes five other deals totaling $175 million over the past two quarters.PR NewswireCrossRoads® Extremity Systems, LLC Announces Launch Of The DynaBunion™ 4D Minimal-Incision Lapidus System For Bunion CorrectionsCrossRoads Extremity Systems announced the launch of its DynaBunion™ 4D Minimal-Incision Lapidus System for surgical bunion repair, enabling surgeons to realign and fuse bones in four dimensions through small incisions. The company credited its 2019 acquisition of Surgical Frontiers, combined with its proprietary Staple Compression Plate™ technology, as key to developing what it believes is a breakthrough for faster bunion healing. CrossRoads also offers the MINIbunion™ system, allowing surgeons to provide patients with two minimally-invasive surgical options for bunion correction.PR NewswireCrossRoads® Extremity Systems, LLC Announces Launch Of The Keel-Lock™ Nitinol Implant System For Foot FusionsCrossRoads Extremity Systems announced the commercial launch of the Keel-Lock Nitinol Implant System for foot fusions, a new product combining a unique keel design with dynamic compression technology. The system is designed for faster surgery, flush implant placement, and less tissue disruption, and joins the company's Comprehensive Nitinol System of six unique platforms. Keel-Lock will address challenges associated with Medial-Double and Triple Arthrodesis procedures in foot and ankle surgery.